Discovery of histone deacetylase 8 (HDAC8)-specific proteolysis-targeting chimeras with anti-cancer activity against hematological malignancies
Shiyang Zhai(University of Bonn), Finn K. Hansen(University of Bonn)
Cited by 0
Related Papers
Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b>
|Journal of Medicinal Chemistry|2023|46
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia
|Journal of Medicinal Chemistry|2022|32
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
|Pharmaceuticals|2023|28
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
|Journal of Medicinal Chemistry|2025|13